表小檗堿
分析標(biāo)準(zhǔn)品,HPLC≥98%
Epiberberine
CAS號(hào)：6873-09-2
分子式：C20H18NO4+
分子量：336.36
MDL：MFCD01547982
貨號(hào) | 規(guī)格/參數(shù)/品牌 | 價(jià)格 | 貨期 |
YJ-B20108-10mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥700.00 | 現(xiàn)貨 |
YJ-B20108-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥1180.00 | 現(xiàn)貨 |
YJ-B20108-100mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥3580.00 | 現(xiàn)貨 |
YJ-B20108-1g | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥9000.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點(diǎn)：260℃
溶解性：在熱水中溶解，在水或乙醇中微溶，在氯仿中極微溶解，在乙mi中不溶。
儲(chǔ)存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。
參考文獻(xiàn)(55篇)
55. [IF=3.1] Mengyuan Li et al."Joint multi-technology applications for etablishing quality evaluation model of Coptidis Rhizoma."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2025 Oct;264:116952
54. [IF=4.1] Yufeng Huang et al."Study on the correlation between alkaloids and tastes of Coptis Rhizome from four species based on UHPLC-QQQ-MS/MS combined with electronic tongue technique."Frontiers in Plant Science.2024 Nov;15:
53. [IF=3.1] Xinyi Jiao et al."A multi-level strategy based on comprehensive two-dimensional liquid chromatography-Q-Orbitrap-mass spectrometry combined with PLS regression model and RT-Ensemble Pred model to intelligently distinguish different geographical locations
52. [IF=2.1] Chen Qinlei et al."Mechanistic evaluation of Jiu Wei Qing Zhi Gao in non-alcoholic fatty liver disease: insights from network Pharmacology and experimental validation."HEREDITAS.2025 Dec;162(1):1-18
51. [IF=2.8] Jingbo Yu et al."Non-target metabolomics unravels the effect and mechanism of Lianpu Drink on spleen-stomach damp-heat syndrome."JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES.2024 Oct;1246:124281
50. [IF=1.8] Panpan Wang et al."In vivo and in vitro chemical composition and biological activity of traditional vs. dispensing granule decoctions of Coptidis Rhizoma: A comparative study."BIOMEDICAL CHROMATOGRAPHY.2024 Jul;:e5960
49. [IF=7.9] Kaifan Hu et al."Effect of Pulsatilla decoction on vulvovaginal candidiasis in mice. Evidences for its mechanisms of action."PHYTOMEDICINE".2024 Mar;:155515
48. [IF=3.4] Jiaping Zhang et al."Effect of the Pulsatilla decoction n-butanol extract on vulvovaginal candidiasis caused by Candida glabrata and on its virulence factors."FITOTERAPIA.2024 Mar;173:105825
47. [IF=5.4] Wenjuan Ma et al."Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;323:117752
46. [IF=7.9] Shan Zhang et al."Enhancing β-Cell Function and Identity in type 2 diabetes: The Protective Role of Coptis deltoidea C. Y. Cheng et Hsiao via Glucose Metabolism Modulation and AMPK Signaling Activation."PHYTOMEDICINE.2024 Jan;:155396
45. [IF=3.4] Rongrong Li et al."Chemical profiles, Differentiation, and Quality evaluation of Radix et Rhizoma Thalictri Foliolosi based on LC-MS."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.10.1016/j.jpba.2023.115747
44. [IF=4.6] Fengge YANG et al."Deciphering chemical and metabolite profiling of Chang-Kang-Fang by UPLC-Q-TOF-MS/MS and its potential active components identification."Chinese Journal of Natural Medicines.2023 Jun;21:459
43. [IF=7.9] Jiangna Yan et al."Blocking LTB4 Signaling-mediated TAMs Recruitment by Rhizoma Coptidis Sensitizes Lung Cancer to Immunotherapy."PHYTOMEDICINE.2023 Jul;:154968
42. [IF=6.5] Wei Liu et al."Genome-wide analysis of bHLH gene family in Coptis chinensis provides insights into the regulatory role in benzylisoquinoline alkaloid biosynthesis."PLANT PHYSIOLOGY AND BIOCHEMISTRY.2023 Aug;201:107846
41. [IF=3.614] Vinay Naithani et al."Preparation of open tubular capillary column covalently coated with polystyrene sulfonate with 4,4′-Azobis(4-cyanopentanoyl chloride) as polymerization initiator for electrochromatographic separation of alkaloids, sulfonamides, and p
40. [IF=0] Xiaoming Yin et al."Assessment of alkaloids from the stems of 14 Berberis species in China."Separation Science Plus.2022 Dec;:202200114
39. [IF=5.195] Kaifan Hu et al."Effects of n-butanol extract of Pulsatilla decoction on the NLRP3 inflammasome in macrophages infected with Candida albicans."JOURNAL OF ETHNOPHARMACOLOGY.2022 Dec;:116041
38. [IF=2.838] Wang Shuo et al."Toxicity and toxicokinetics of the ethanol extract of Zuojin formula."BMC Complementary Medicine and Therapies.2022 Dec;22(1):1-14
37. [IF=3.571] Yuefei Wang et al."Identification and characterization of major alkaloid from Sinomenium acutum stem and their metabolites after oral administration in rat plasma, urine, bile and feces based on UPLC-Q-TOF/MS."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANAL
36. [IF=5.195] Mengmeng Song et al."Homeostatic regulation of the aryl hydrocarbon receptor-cytochrome P450 1a axis by Scutellaria baicalensis-Coptis chinensis herb pair and its main constituents."JOURNAL OF ETHNOPHARMACOLOGY.2022 Jul;:115545
35. [IF=6.656] Ye Yang et al."Coptis chinensis polysaccharides dynamically influence the paracellular absorption pathway in the small intestine by modulating the intestinal mucosal immunity microenvironment."PHYTOMEDICINE.2022 Sep;104:154322
34. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950
33. [IF=3.463] Xiao-Meng Liu et al."Comparative transcriptome analysis provides novel insights into the molecular mechanism of berberine biosynthesis in Coptis chinensis."Sci Hortic-Amsterdam. 2022 Jan;291:110585
32. [IF=4.759] Yi Zhang et al."Screening of inhibitors against histone demethylation jumonji domain-containing protein 3 by capillary electrophoresis."J Chromatogr A. 2020 Feb;1613:460625
31. [IF=5.81] Zhao Jing et al."Intra-Herb Interactions: Primary Metabolites in Coptidis Rhizoma Extract Improved the Pharmacokinetics of Oral Berberine Hydrochloride in Mice."Front Pharmacol. 2021 Jun;0:1426
30. [IF=6.4] Jing Zhao et al."Natural Nano-Drug Delivery System in Coptidis Rhizoma Extract with Modified Berberine Hydrochloride Pharmacokinetics."Int J Nanomed. 2021; 16: 6297–6311
29. [IF=1.618] Yang Yanfang et al."Determination of Alkaloid Contents in Various Tissues of Coptis Chinensis Franch. by Reversed Phase-High Performance Liquid Chromatography and Ultraviolet Spectrophotometry."J Chromatogr Sci. 2017 May;55(5):556-563
28. [IF=1.618] Li Jiang-Yan et al."Seasonal Variation of Alkaloid Contents and Anti-Inflammatory Activity of Rhizoma coptidis Based on Fingerprints Combined with Chemometrics Methods."J Chromatogr Sci. 2015 Aug;53(7):1131-1139
27. [IF=3] Zhang Pengyu et al."Discovery of novel antagonists on β2-adrenoceptor from natural products using a label-free cell phenotypic assay."N-S Arch Pharmacol. 2018 Dec;391(12):1411-1420
26. [IF=3.197] Bingxin Ma et al."Coptis chinensis inflorescence ameliorates hyperglycaemia in 3T3-L1 preadipocyte and streptozotocin-induced diabetic mice."J Funct Foods. 2016 Mar;21:455
25. [IF=3.935] Ka-Yan Kwok et al."Quality evaluation of commercial Huang-Lian-Jie-Du-Tang based on simultaneous determination of fourteen major chemical constituents using high performance liquid chromatography."J Pharmaceut Biomed. 2013 Nov;85:239
24. [IF=4.451] Bingxin Ma et al."Coptis chinensis inflorescence and its main alkaloids protect against ultraviolet-B-induced oxidative damage."J Funct Foods. 2013 Oct;5:1665
23. Xu, Jun. "Improved approaches and strategies for analyzing decoctions of medicinal herbs." (2016).
22. Yang, Yanfang, et al. "Determination of alkaloid contents in various tissues of Coptis chinensis Franch. by reversed phase-high performance liquid chromatography and ultraviolet spectrophotometry." Journal of chromatographic science 55.5 (2017): 556-563. h
21. Ma, Bingxin, et al. "Coptis chinensis inflorescence and its main alkaloids protect against ultraviolet-B-induced oxidative damage." Journal of Functional Foods 5.4 (2013): 1665-1672.https:##doi.org/10.1016/j.jff.2013.07.010
20. Ma, Bingxin, et al. "Coptis chinensis inflorescence ameliorates hyperglycaemia in 3T3-L1 preadipocyte and streptozotocin-induced diabetic mice." Journal of Functional Foods 21 (2016): 455-462.https:##doi.org/10.1016/j.jff.2015.12.021
19. 康念欣,袁炎炎,張瀟,路穎慧,李晴霞,李飛,譚鵬.酒黃連HPLC特征圖譜的建立及聚類分析和主成分分析[J].世界科學(xué)技術(shù)-中醫(yī)藥現(xiàn)代化,2020,22(08):2790-2798.
18. 彭平,熊少哲,張蓓,易劍平,杜菁,楊璇,范國(guó)強(qiáng),顧海鷗,王志斌.基于全方特征圖譜質(zhì)量表征的芩連制劑質(zhì)量評(píng)價(jià)研究[J].中草藥,2021,52(05):1312-1322.
17. 吳逸晨, 謝輝, 毛春芹,等. 復(fù)方甘草清瘍合劑HPLC指紋圖譜[J]. 中成藥, 2019, 041(009):2251-2256.
16. 李聽弦, 李蒙, 張志,等. 基于高效液相色譜指紋圖譜及紅外光譜評(píng)價(jià)黃連及其炮制品質(zhì)量差異[J]. 中南藥學(xué), 2019, 017(004):556-560.
15. 張久旭, 范晶, 李小陽(yáng),等. 基于內(nèi)在品質(zhì)的黃連藥材現(xiàn)代產(chǎn)地加工方法研究[J]. 遼寧中醫(yī)藥大學(xué)學(xué)報(bào), 2019, v.21;No.185(09):74-77.
14. 張瀟, 張亞麗, 苗祥貞,等. 黃連不同炮制品及組分的抗腫瘤活性與6種生物堿含量相關(guān)性研究[J]. 中華中醫(yī)藥雜志, 2019, v.34(06):350-353.
13. 張純剛, 唐靜雅, 于琛琛,等. 黃連五種主要生物堿的提取純化及含量測(cè)定[J]. 中國(guó)現(xiàn)代中藥, 2018, 20(09):116-119+126.
12. 李亞杰, 龍瀾, 楊永康,等. 恩施道地藥材黃連的質(zhì)量標(biāo)準(zhǔn)研究[J]. 湖北民族學(xué)院學(xué)報(bào):自然科學(xué)版, 2012, 000(004):443-445.
11. 劉洋, 尹秀文, 王子禹,等. 黃連提取物的中藥生物藥劑學(xué)分類系統(tǒng)研究[J]. 中國(guó)中藥雜志, 2017, 21(v.42):87-94.
10. 彭平, 張蓓, 杜菁,等. 基于天然麝香-牛黃和4個(gè)植物藥味的安宮牛黃丸特征圖譜質(zhì)量表征研究[J]. 中草藥, 2019(14).
9. 柳鑫,楊艷芳,宋紅萍,張小波,黃璐琦,吳和珍.基于MaxEnt和ArcGIS的黃連生長(zhǎng)適宜性區(qū)劃研究[J].中國(guó)中藥雜志,2016,41(17):3186-3193.
8. 張欣,倪健,郭琳,杜梓萱,王美玲,冷新,游龍?zhí)?/span>,王允亮,李軍祥,尹興斌.多指標(biāo)優(yōu)選清腸溫中顆粒中黃連、三七、青黛的醇提工藝[J].中國(guó)中醫(yī)藥信息雜志,2018,25(10):73-78.
7. 彭平, 解素花, 彭平安,等. 基于UPLC-PDA生物堿指標(biāo)性成分含量和特征圖譜的不同產(chǎn)區(qū)黃連(味連)整體質(zhì)量表征研究[J]. 世界科學(xué)技術(shù)-中醫(yī)藥現(xiàn)代化, 2019(10).
6. 范文碩 王允亮 王之洋 等. 和降顆粒乙醇提取工藝研究及初步藥效學(xué)評(píng)價(jià)[J]. 中南藥學(xué) 2018 016(004):488-491.
5. 馬冰馨 梁佳文 李興會(huì) 何敬勝 童靜 王有為.反相高效液相色譜法同時(shí)測(cè)定黃連花薹及黃連花茶中6種生物堿的含量[J].食品安全質(zhì)量檢測(cè)學(xué)報(bào) 2014 5(06):1602-1607.
4. 李聽弦 李蒙 張志 等. 一測(cè)多評(píng)法測(cè)定不同味連飲片中6個(gè)生物堿類成分的含量[J]. 藥物分析雜志 2018 038(007):1132-1138.
3. 皮文霞 朱鑫仙 方婷 等. HPLC同時(shí)測(cè)定"三熱論"方各純化部位中藥根堿、表小檗堿、黃連堿、巴馬汀和小檗堿的含量[J]. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志 2012 18(14):110-113.
2. 李淑嬌 王宇卿. HPLC-ABTS-DAD-Q-TOF/MS在線篩選黃連抗氧化活性物質(zhì)[J]. 中國(guó)中藥雜志 2018(12).
1. 張大軍 王兆華. 2015年版中國(guó)藥典含黃連成方制劑的統(tǒng)計(jì)分析及黃連提取工藝的試驗(yàn)研究[J]. 山東化工 2020 049(001):67-68 70.
從2011年開始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實(shí)驗(yàn)技術(shù)及論文潤(rùn)色服務(wù)，協(xié)助客戶各類實(shí)驗(yàn)服務(wù)及論文潤(rùn)色十多年，是您值得信賴的科研合作伙伴!
如果您受時(shí)間、試驗(yàn)條件等限制而無(wú)法完成您的課題研究，歡迎您與我們聯(lián)系。
實(shí)驗(yàn)技術(shù)服務(wù)：
實(shí)驗(yàn)室代做實(shí)驗(yàn)項(xiàng)目
| |||
細(xì)胞熒光染料標(biāo)記檢測(cè)實(shí)驗(yàn)
| |||
| |||
染色質(zhì)免疫沉淀分析(CLIP)實(shí)驗(yàn)服務(wù)
| |||
| |||
|
